BioNTech SE (BNTX) Notes Payables (2019 - 2023)

BioNTech SE (BNTX) has 5 years of Notes Payables data on file, last reported at $2.5 million in Q4 2023.

• For the quarter ending Q4 2023, Notes Payables rose 15.5% year-over-year to $2.5 million; the trailing twelve-month figure through Dec 2023 stood at $2.5 million (up 15.5% YoY), and the FY2023 full-year result was $2.5 million, up 15.5% from the prior year.
• Notes Payables rose to $2.5 million in Q4 2023, from $2.3 million in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $344.9 million in Q4 2021 to a low of $2.1 million in Q4 2022.
• A 5-year average of $170.2 million and a median of $197.4 million in 2022 frame the typical range for Notes Payables.
• Across the five-year window, Notes Payables surged 3078.92% in 2021 and sank 99.38% in 2022, its largest moves.
• Tracing BNTX's Notes Payables over 5 years: stood at $76.3 million in 2019, then sank by 85.77% to $10.8 million in 2020, then surged by 3078.92% to $344.9 million in 2021, then slumped by 99.38% to $2.1 million in 2022, then rose by 15.5% to $2.5 million in 2023.
• Business Quant data shows BNTX's Notes Payables at $2.5 million in Q4 2023, $2.3 million in Q1 2023, and $2.1 million in Q4 2022.